from Reuters: Health News https://ift.tt/2uLsOlB
via IFTTT
Thursday, April 4, 2019
Health Canada plans to suspend Allergan's breast implant license
The Canadian health regulator said on Thursday it was advising Allergan Plc that it plans to suspend the license for the Botox-maker's Biocell breast implants.
from Reuters: Health News https://ift.tt/2uLsOlB
via IFTTT
from Reuters: Health News https://ift.tt/2uLsOlB
via IFTTT
0 comments:
Post a Comment